MENU
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Earnings Date & Reports

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

A.I. Advisor
published Earnings

NVO is expected to report earnings to rise 3.12% to 95 cents per share on November 05

Novo-Nordisk A/S NVO Stock Earnings Reports
Q3'25
Est.
$0.96
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
The last earnings report on August 06 showed earnings per share of 92 cents, missing the estimate of 93 cents. With 1.71M shares outstanding, the current market capitalization sits at 224.52B.
View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com